190 related articles for article (PubMed ID: 29481759)
1. Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA
Knutson DE; Kodali R; Divović B; Treven M; Stephen MR; Zahn NM; Dobričić V; Huber AT; Meirelles MA; Verma RS; Wimmer L; Witzigmann C; Arnold LA; Chiou LC; Ernst M; Mihovilovic MD; Savić MM; Sieghart W; Cook JM
J Med Chem; 2018 Mar; 61(6):2422-2446. PubMed ID: 29481759
[TBL] [Abstract][Full Text] [Related]
2. The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats.
Savić MM; Milinković MM; Rallapalli S; Clayton T; Joksimović S; Van Linn M; Cook JM
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1179-93. PubMed ID: 19265570
[TBL] [Abstract][Full Text] [Related]
3. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
[TBL] [Abstract][Full Text] [Related]
4. Attaining in vivo selectivity of positive modulation of α3βγ2 GABA
Batinić B; Stanković T; Stephen MR; Kodali R; Tiruveedhula VV; Li G; Scholze P; Marković BD; Obradović AL; Ernst M; Cook JM; Savić MM
Eur Neuropsychopharmacol; 2018 Aug; 28(8):903-914. PubMed ID: 29891214
[TBL] [Abstract][Full Text] [Related]
5. K+ channel TASK-1 knockout mice show enhanced sensitivities to ataxic and hypnotic effects of GABA(A) receptor ligands.
Linden AM; Aller MI; Leppä E; Rosenberg PH; Wisden W; Korpi ER
J Pharmacol Exp Ther; 2008 Oct; 327(1):277-86. PubMed ID: 18660435
[TBL] [Abstract][Full Text] [Related]
6. Flavonoid compounds isolated from Tibetan herbs, binding to GABA
Liu Z; Silva J; Shao AS; Liang J; Wallner M; Shao XM; Li M; Olsen RW
J Ethnopharmacol; 2021 Mar; 267():113630. PubMed ID: 33246118
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar gamma-aminobutyric acid type A receptors: pharmacological subtypes revealed by mutant mouse lines.
Mäkelä R; Uusi-Oukari M; Homanics GE; Quinlan JJ; Firestone LL; Wisden W; Korpi ER
Mol Pharmacol; 1997 Sep; 52(3):380-8. PubMed ID: 9281599
[TBL] [Abstract][Full Text] [Related]
8. Insights into functional pharmacology of α₁ GABA(A) receptors: how much does partial activation at the benzodiazepine site matter?
Joksimović S; Varagic Z; Kovačević J; Van Linn M; Milić M; Rallapalli S; Timić T; Sieghart W; Cook JM; Savić MM
Psychopharmacology (Berl); 2013 Nov; 230(1):113-23. PubMed ID: 23685860
[TBL] [Abstract][Full Text] [Related]
9. 2'-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA(A) receptors.
Karim N; Curmi J; Gavande N; Johnston GA; Hanrahan JR; Tierney ML; Chebib M
Br J Pharmacol; 2012 Feb; 165(4):880-96. PubMed ID: 21797842
[TBL] [Abstract][Full Text] [Related]
10. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies.
Razack S; Kandikattu HK; Venuprasad MP; Amruta N; Khanum F; Chuttani K; Mishra AK
Metab Brain Dis; 2018 Oct; 33(5):1533-1549. PubMed ID: 29934858
[TBL] [Abstract][Full Text] [Related]
12. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Besnard F; Costa B; Montali M; Martini C; Fohlin J; De Siena G; Aiello PM
J Med Chem; 2005 Oct; 48(21):6756-60. PubMed ID: 16220991
[TBL] [Abstract][Full Text] [Related]
13. Ligands for the benzodiazepine binding site--a survey.
Teuber L; Wätjens F; Jensen LH
Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
[TBL] [Abstract][Full Text] [Related]
14. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
[TBL] [Abstract][Full Text] [Related]
15. Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress.
Vinkers CH; Klanker M; Groenink L; Korte SM; Cook JM; Van Linn ML; Hopkins SC; Olivier B
Psychopharmacology (Berl); 2009 Jun; 204(2):299-311. PubMed ID: 19169673
[TBL] [Abstract][Full Text] [Related]
16. TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via α2GABA
Neumann E; Ralvenius WT; Acuña MA; Rudolph U; Zeilhofer HU
Neuropharmacology; 2018 Dec; 143():71-78. PubMed ID: 30240781
[TBL] [Abstract][Full Text] [Related]
17. GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background.
Pattij T; Groenink L; Oosting RS; van der Gugten J; Maes RA; Olivier B
Eur J Pharmacol; 2002 Jun; 447(1):67-74. PubMed ID: 12106804
[TBL] [Abstract][Full Text] [Related]
18. Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice.
Heldt SA; Ressler KJ
J Neurosci; 2010 May; 30(21):7139-51. PubMed ID: 20505082
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of γ-aminobutyric acid type A receptor (GABA
Mundy PC; Pressly B; Carty DR; Yaghoobi B; Wulff H; Lein PJ
Toxicol Appl Pharmacol; 2021 Sep; 426():115643. PubMed ID: 34265354
[TBL] [Abstract][Full Text] [Related]
20. Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects.
Obradović ALj; Joksimović S; Poe MM; Ramerstorfer J; Varagic Z; Namjoshi O; Batinić B; Radulović T; Marković B; Roth BL; Sieghart W; Cook JM; Savić MM
Brain Res; 2014 Mar; 1554():36-48. PubMed ID: 24472579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
